This white paper from IQVIA – an associate member of AdvaMed – discusses how global markets and specific therapeutic areas are poised for growth over the next decade.
This report outlines a key data-driven summary of the U.S. COVID testing supply.
This report examines cumulative data from the first two years of the COVID Test Registry to demonstrate the mobilization of the diagnostics industry over the course of the pandemic.
Read background information on how AdvaMedDx’s members produce IVD tests to detect COVID-19.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
Listen to AdvaMed's Podcast
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
The Chinese government announced a process to export particular devices without NMPA approval.
Chinese Government’s Evaluation Process Of Manufacturers’ Standards And Qualifications For Relevant Epidemic Prevention Products
View a flow chart of the evaluation process.
This guidance helps member companies support decision-making and mitigate compliance risks.
This infographic depicts the process of COVID-19 diagnostic tests from patient sample to test results.